Sign inJoin waitlistJoin the waitlist

AM

Adel Mandl

Principal Investigator · Johns Hopkins University School of Medicine

Credentials: · · · · · ·

History

Johns Hopkins University School of Medicine
Present

Medical Oncology
2019–2021
Endocrinology, Diabetes, and Metabolism
2017–2019
Internal Medicine
2014–2017
Doctor of Medicine
2001–2005

Research

Endoplasmic reticulum stress as a novel therapeutic target in heart diseases
Review · Cardiovascular & hematological disorders drug targets · 2007 · 113 citations
Puma deletion delays cardiac dysfunction in murine heart failure models through attenuation of apoptosis
Circulation · 2011 · First of 5 authors · 48 citations
Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation
The Journal of Clinical Endocrinology & Metabolism · 2020 · 27 citations

JB
Jenny Blau
7 papers
LW
Lee Weinstein
7 papers
MC
Michael Carducci
7 papers
WS
William Simonds
6 papers
SD
Samuel Denmeade
5 papers
CP
Channing Paller
4 papers
Emmanuel Antonarakis
4 papers
MM
Mark Markowski
4 papers
CM
Catherine Marshall
3 papers
Corina Millo
3 papers
Jaydira Del Rivero
3 papers · 3 as a fellow
KP
Karel Pacak
3 papers

Clinical trials

Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2020–2027
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
2025–2031
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Site PI · Recruiting · Phase 1, Phase 2
Pathos AI, Inc.
2025–2029